logo
Newcastle University kidney drug research 'may be life-changing'

Newcastle University kidney drug research 'may be life-changing'

BBC News5 days ago
Early withdrawal of a treatment for people with a rare kidney disease is possible without relapse, safer for patients and saves the NHS millions of pounds, researchers say.Atypical Haemolytic Uraemic Syndrome (aHUS) is a life-threatening condition caused by an uncommon defect in the immune system which, in the past, led to kidney failure.A study by Newcastle University has found most patients can stop taking the drug eculizumab after six months and their disease will not return. Prof Neil Sheerin, who led the study, said the findings had "the potential to significantly change the way we manage aHUS and this may be life-changing for some patients".
Ending the use of the drug after six months could lead to NHS savings of £4.2m per patient over their lifetime, the university said.Health chiefs previously recommended patients stay on eculizumab for the rest of their lives although that leads to an increased risk of meningococcal sepsis.
'I feel like myself again'
Twenty-eight people, aged two to 59, from England and Scotland and who had been on eculizumab for at least six months, took part in the trial.All patients had their treatment withdrawn. Only four participants' kidney disease returned and the remaining 24 have remained aHus-free to date, the university said.Among those taking part was Louise Percival, of York, who was diagnosed with aHus in 2017.The 35-year-old said she had suffered several side effects, such as migraines, hair loss and breathlessness, before being taken off eculizumab during the trial.She described the findings as fantastic."When I was diagnosed with aHUS I felt overwhelmed as it was a huge burden to live with," she said. "It was life-changing as it's something that will never go away."I strongly disliked the eculizumab infusions as they had to be given religiously every two weeks, which impacted my holidays and social events."I'm a very active person, enjoying hiking and the gym, so the side effects and time needed for the treatment were detrimental to my quality of life."I have a fear of needles, so having a cannula put in my arm every fortnight was very distressing."All of the side effects disappeared and I feel like myself again."
Prof Sheerin said when a patient initially started treatment for aHUS "they faced a lifetime of eculizumab and the dangers associated with it"."Now we have shown that many people can stop the treatment, freeing them from the burden of regular intravenous injections and removing risk of serious infection associated with the drug," he said."In addition, significant efficiency savings for the NHS of £110.4m over five years could be realised in this patient population through more targeted use of this high-cost treatment."The study was funded by the National Institute for Health and Care Research and published in The Lancet Regional Health Europe.
Follow BBC North East on X, Facebook, Nextdoor and Instagram.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Couple expecting identical twin girls face heartbreaking dilemma that could see them save one baby to lose the other
Couple expecting identical twin girls face heartbreaking dilemma that could see them save one baby to lose the other

Daily Mail​

time18 minutes ago

  • Daily Mail​

Couple expecting identical twin girls face heartbreaking dilemma that could see them save one baby to lose the other

When Jack Alexander and his partner went for their early 16-week baby scan, they were delighted to discover they were expecting identical twin girls. But their happiness quickly turned to 'devastation' as they were told their babies were suffering from twin-to-twin transfusion syndrome (TTTS) - a rare condition which sees one fetus starved of blood and fluid. The couple were soon faced with a heartbreaking dilemma: let one twin die to save the other - or undertake risky laser surgery for a chance at saving both. Determined to fight for both girls, the couple were referred to St George's Hospital in London for specialist treatment - a six-hour round trip from their home in Corfe Mullen, Dorset, which they could be required to make every week. Jack, who has been forced to launch a GoFundMe, told the Daily Mail: 'It's devastating knowing that it could be 50/50. I'm just trying to be positive for my partner as she is very lost at the moment. 'They said obviously if we don't have it done, there is a risk that we could lose one. 'But obviously it does carry risks to it as well.' Jack, a chef, explained 'Twin One' is currently one week behind 'Twin Two' in their development, with midwives unable to see her bladder. 'It was a big shocker for us. We went for our 12-week scan and we didn't know we were having twins, and [the midwife] said we've got identical twins in there,' he said. 'This made us emotional anyway, knowing this was a happy thing. We went for a private scan two days before our 16-week one, just for an early gender reveal, and she said Twin Two has got more fluid in their sack than Twin One. 'She said this could be a problem. 'We hung around, and two days later we went for our 16-week scan at Bournemouth hospital, and they said that they can't see the bladder of Twin One.' The couple, who have three children between them from previous relationships, said they are willing to take the risks that come with laser treatment for a fighting chance of saving both girls. However, this means leaving behind their children - aged six, 10 and 13, for weekly visits to London that will be costly due to travel and hotel stays. 'We have to travel up to London by car. Without traffic it's just over three hours. I think we'll have to do this every week near enough. They've classed her as high risk, so they're doing weekly checks all the time as well,' Jack said. 'We have to travel all the way up, and if she does have this laser treatment, she's going to have to stay up there for a few days, recover, and see how she is.' He added: 'You've got to be positive through this, otherwise you're going to put yourself down. It is heartbreaking, but I need to be strong for my Mrs as well.' The couple have launched a GoFundMe in a desperate bid to raise the funds they will need to travel to London. TTTS is a rare but life-threatening condition that affects 10 to 15 per cent of identical twins that share a placenta (monochorionic twins) This year, former Little Mix star Jesy Nelson revealed she had been diagnosed with pre-twin-to-twin transfusion syndrome, meaning one or both babies could have died. She had to undergo an emergency procedure in March after suffering complications, and was advised to remain in hospital until she was at least 32 weeks into her pregnancy. In May, she confirmed both girls were safe and well - three days after giving birth prematurely. Asma Khalil, Professor of Obstetrics and Maternal Fetal Medicine at St George's Hospital, University of London, recommended that families facing a similar situation to Jesy and her partner contact the charity, Twins Trust, for resources and support. She said: 'TTTS is a rare but life-threatening condition that affects 10 to 15 per cent of identical twins that share a placenta (monochorionic twins). 'If left untreated, you can lose one or both babies in up to 80% of the cases. Laser surgery is the recommended treatment. In 85 per cent of these pregnancies, at least one baby survives and in up to 70 per cent of cases both babies survive. 'The laser surgery is usually performed under local anaesthesia and it usually lasts for less than 30 minutes. A fetoscope (thin camera) is inserted into the womb via a small incision. Abnormal vascular connections in the placenta are sealed using the laser. 'The laser surgery is not a risk-free procedure. It can trigger early birth or a miscarriage. The pregnancy still needs close monitoring. 'Parents could lose one or both babies. As this is a very stressful time for the family, the parents often need emotional support.' If you would like to help Jack and his partner, visit their GoFundMe. WHAT IS TWIN-TWIN TRANSFUSION SYNDROME? Twin-twin transfusion syndrome is a rare but serious condition that can occur in identical pregnancies when twins share a placenta. Abnormal blood vessel connections form in the placenta and prevent blood from flowing evenly between the babies. One twin then becomes dehydrated, which affects its growth. The other develops high blood pressure and produces too much urine. This leads to an enlarged bladder and excessive amounts of amniotic fluid, which can put a strain on the twin's heart, leading to heart failure. Without treatment, TTTS can be fatal for both twins. The condition occurs in about around 15 per cent of identical twins who share a placenta, according to the charity Twins Trust. Around 300 twins die from the condition every year in the UK, while 6,000 babies are affected annually in the US. Draining excess amniotic fluid can help to improve blood flow. If this is not enough, laser surgery is used to seal shut abnormal blood vessels and permanently disconnect them. The surgeon then drains excess fluid. Even when treated successfully, most TTTS babies are born premature. However, the majority go on to have long, healthy lives.

New tech set to give users ‘super' hearing
New tech set to give users ‘super' hearing

The Independent

timean hour ago

  • The Independent

New tech set to give users ‘super' hearing

Scientists have developed artificial intelligence-powered smart glasses designed to provide enhanced hearing. These spectacles use a camera to translate lip movements into clear speech, benefiting individuals with hearing difficulties or those in noisy environments. Developed by a team from Heriot-Watt, Edinburgh, Napier, and Sterling universities, the technology aims to give 'superpowers' to existing hearing aids. The system processes sound data remotely via high-speed internet, enabling the AI to isolate specific voices even when multiple people are speaking. Researchers are in discussions with hearing aid manufacturers and anticipate a working version by 2026, with plans to make the cloud-based model publicly available.

Chesterfield heartbreakingly announce owner Phil Kirk's cancer treatment hasn't worked and he'll enter palliative care
Chesterfield heartbreakingly announce owner Phil Kirk's cancer treatment hasn't worked and he'll enter palliative care

The Sun

timean hour ago

  • The Sun

Chesterfield heartbreakingly announce owner Phil Kirk's cancer treatment hasn't worked and he'll enter palliative care

CHESTERFIELD have confirmed the tragic news that owner Phil Kirk's cancer treatment has not been successful. Phil, who co-owns the League Two club with brother Ashley Kirk, will now enter palliative care. 4 A club statement announcing the heartbreaking news read: "Chesterfield Football Club owner Phil Kirk has been undergoing treatment for cancer in recent months. "Sadly, despite the best efforts of his medical team, the treatment has not been successful. Phil is now entering a period of palliative care. "Phil and his family remain deeply committed to the ongoing support of the club and its community. "The club will continue to operate as normal, and we are united in ensuring Phil's vision and values remain at the heart of everything we do." Phil was diagnosed with inoperable cancer in March. The outlook at the time was grim, and sadly the latest updates confirmed the club's worst fears. A club statement at the beginning of his treatment stated: "Over the next few months, he will be receiving treatment to prolong his life, but this is not expected to deliver a cure." 4 Fans and clubs from around the EFL have come forward with their condolences following the heartbreaking update. One Spireite fan gave testimony on X of the positive influence Phil and Ashley have had on the club since taking over in 2022. They said: "In all the 72 years of watching Chesterfield FC this is the saddest news I can ever remember coming from our club. "This man has made this club loved by young and old Phil this club and fans will never forget you." 4 4 Another fan added: This is deeply sad news. Phil, Ashley & everyone involved should be proud of the work done at town since their involvement. "His legacy will continue and town are in a much better place than when the Kirk family invested. Thoughts go to all." Since taking over, the brothers have invested over a million pounds on their way to earning the club promotion to the EFL at the end of the 2023-24 season. Their impressive campaign last season, their first in the EFL in six years, saw them earn their way into the playoffs with a seventh-place finish, where they were knocked out by Walsall. Their steady rise through the footballing pyramid, and the number of touching tributes from fans and rivals, is symbolic of the passion and the positive influence that the brothers have brought to the community in their limited time with the club thus far.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store